Chronic Pain Induces Anxiety with Concomitant Changes in Opioidergic Function in the Amygdala
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Clinically, it has been reported that chronic pain induces depression, anxiety, and reduced quality of life. The endogenous opioid system has been implicated in nociception, anxiety, and stress. The present study was undertaken to investigate whether chronic pain could induce anxiogenic effects and changes in the opioidergic function in the amygdala in mice. We found that either injection of complete Freund's adjuvant (CFA) or neuropathic pain induced by sciatic nerve ligation produced a significant anxiogenic effect at 4 weeks after the injection or surgery. Under these conditions, the selective mu-opioid receptor agonist [D-Ala2,N-MePhe4,Gly5-ol]-enkephalin (DAMGO)- and the selective delta-opioid receptor agonist (+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC80)-stimulated [35S]GTPgammaS binding in membranes of the amygdala was significantly suppressed by CFA injection or nerve ligation. CFA injection was associated with a significant increase in the kappa-opioid receptor agonist 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide hydrochloride (ICI199,441)-stimulated [35S]GTPgammaS binding in membranes of the amygdala. The intracerebroventricular administration and microinjection of a selective mu-opioid receptor antagonist, a selective delta-opioid receptor antagonist, and the endogenous kappa-opioid receptor ligand dynorphin A caused a significant anxiogenic effect in mice. We a…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increases in the GTPgs binding of k-opioid receptor-specific ligands in the amygdala were associated with anxiety that was produced by Complete Freund's Adjuvantinduced chronic pain or sciatic nerve ligation-induced neuropathic pain (Narita et al., 2006).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Narita et al., 2006
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963 · cited 1×
“A guide cannula (AG-9, Eicom Co., Kyoto, Japan) was implanted into the basolateral amygdala (from bregma: posterior 2.8 mm, lateral + 5.0 mm, ventral 7.9 mm) according to the atlas of Paxinos and Watson (1998).”
InfluentialThe rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE
HALEY, T. J., & McCORMICK, W. G. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb01354.x · Cited by 1,526 · cited 2×
“Intracerebroventricular administration was performed as described previously (Haley and McCormick, 1957).”
MethodOpioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292 · cited 3×
“The distributions of m-, d-, and k-opioid receptor mRNAs overlap in many brain regions including the amygdala (Mansour et al, 1995).”
BackgroundInfluentialCloning of a Delta Opioid Receptor by Functional Expression
Evans, C. J., Keith, D. E., Morrison, H., Magendzo, K., & Edwards, R. H. (1992) · Science · doi:10.1126/science.1335167 · Cited by 1,233 · cited 2×
“Three opioid receptor types, m-, d-, and k-opioid receptors, have been successfully cloned (Evans et al, 1992; Kieffer et al, 1992; Chen et al, 1993; Fukuda et al, 1993; Meng et al, 1993; Wang et al, 1993; Yasuda et al, 1993).”
BackgroundAnatomy of CNS opioid receptors
Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H., & Watson, S. J. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90093-8 · Cited by 1,194
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010 · cited 1×
“Three opioid receptor types, m-, d-, and k-opioid receptors, have been successfully cloned (Evans et al, 1992; Kieffer et al, 1992; Chen et al, 1993; Fukuda et al, 1993; Meng et al, 1993; Wang et al, 1993; Yasuda et al, 1993).”
BackgroundPsychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857 · cited 2×
“Furthermore, k agonists produce a dysphoria similar to that noted in depression and chronic stress (Pfeiffer et al, 1986).”
BackgroundRegional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain
Zubieta, J.-K., Smith, Y. R., Bueller, J. A., Xu, Y., Kilbourn, M. R., Jewett, D. M., Meyer, C. R., Koeppe, R. A., & Stohler, C. S. (2001) · Science · doi:10.1126/science.1060952 · Cited by 841 · cited 2×
“As previously reported in healthy human subjects, sustained pain induces a reduction of m-opioid receptor availability in the amygdala as measured by positron emission tomography (Zubieta et al, 2001).”
MethodMolecular cloning and functional expression of a mu opioid receptor from rat brain
Chen, Y., Mestek, A., Liu, J., Hurley, A., & Yu, L. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90214-3 · Cited by 810 · cited 1×
“Three opioid receptor types, m-, d-, and k-opioid receptors, have been successfully cloned (Evans et al, 1992; Kieffer et al, 1992; Chen et al, 1993; Fukuda et al, 1993; Meng et al, 1993; Wang et al, 1993; Yasuda et al, 1993).”
Background
Cited by
Items 201–289 of 289
Parrilla-Carrero, J., Kaigler, K. F., Hartshorn, G. H., Fadel, J. R., & Wilson, M. A. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100197 · Cited by 10
“2008; Lutz and Kieffer, 2013; Wilson and McDonald, 2019), and injection of MOR agonists or antagonists into the CeA alters anxiety-related responses (Rogers and File, 1979; Narita et al., 2006; Wilson and Junor, 2008).”
Trait anxiety affects the orofacial nociceptive response in rats
Matos, A. C. C., Teixeira-Silva, F., Goes, T. C., Quintans‐Júnior, L. J., Júnior, R. L. C. D. A., & Bonjardim, L. R. (2011) · Biological Research · doi:10.4067/s0716-97602011000400007 · Cited by 9
“This means that acute orofacial pain does not present an anxiogenic effect, contrary to what has been shown for chronic pain by Narita et al., 2006.”
ResultWilson, M. A., & McDonald, A. J. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-815134-1.00008-8 · Cited by 9
Ji, G., Presto, P., Kiritoshi, T., Chen, Y., Navratilova, E., Porreca, F., & Neugebauer, V. (2024) · Cells · doi:10.3390/cells13080705 · Cited by 9
“These results are consistent with the anxiogenic effects of intra-amygdala (basolateral) injection of dynorphin [53] and our previous report that a KOR agonist (U-69,593) administered into the CeA increased emotional-affective responses, anxiety-like behaviors, and avoidance behaviors as well as…”
ResultHestehave, S., Florea, R., Fedorec, A. J. H., Jevic, M., Mercy, L., Wright, A., Morgan, O. B., Brown, L. A., Peirson, S. N., & Géranton, S. M. (2024) · PAIN Reports · doi:10.1097/pr9.0000000000001213 · Cited by 12
“The absence of anxiety-like behavior aligns with similar studies 46 but not with others, 41,42 reflecting the well-known complexity of the field.”
Alotaibi, G., Khan, A., & Rahman, S. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115440 · Cited by 8
Liu, A.-R., Lin, Z., Wei, M., Tang, Y., Zhang, H., Peng, X.-G., Li, Y., Zheng, Y., Tan, Z., Zhou, L., et al. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01667-1 · Cited by 7
“The times of rodents’ entrance of different arena [35] were evaluated and statistically analyzed.”
BackgroundOpioid κ Receptors as a Molecular Target for the Creation of a New Generation of Analgesic Drugs
Grechko, O. Y., Спасов, А. А., & Штарёва, Д. М. (2016) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-016-1388-z · Cited by 7
Persistent inflammatory pain alters sexually-motivated behavior in male rats
Pitcher, M. H., Tarum, F., Lehmann, M. L., & Bushnell, M. C. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.09.001 · Cited by 8
“Considering that CFA-induced inflammation can, over time, lead to deficits in affective behavior [55,59,67,78] and elevated stress [43,60], we assessed the effects of CFAinduced inflammatory pain on plasma corticosterone (Fig.”
Ulans, A., Brooks, G. C., & Jacobs, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-67965-z · Cited by 8
Zhou, Q., Zhong, Q., Liu, Z., Zhao, Z., Wang, J., & Zhang, Z. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70227 · Cited by 8
Jackson, M., Foret, B. L., Fontenot, J. A., Hasselschwert, D. L., Smith, J., Romero, E., & Smith, K. M. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25128 · Cited by 8
Behavioral Changes Following Experimentally-Induced Acute Myocardial Infarction in Rats
Banožić, A., Grković, I., Puljak, L., & Sapunar, D. (2014) · International Heart Journal · doi:10.1536/ihj.13-275 · Cited by 6
Segarra, A. B., Prieto, I., Martínez‐Cañamero, M., Ruiz-Sanz, J. I., Ruiz‐Larrea, M. B., de Gasparo, M., Banegas, I., Zórad, Š., & Ramírez‐Sánchez, M. (2019) · Endocrine Regulations · doi:10.2478/enr-2019-0007 · Cited by 6
Bolouri-Roudsari, A., Baghani, M., Askari, K., Mazaheri, S., & Haghparast, A. (2023) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000737 · Cited by 6
“There is now widespread agreement that pain can lead to various functional brain diseases, including anxiety, depression, and sensory impairment when it becomes persistent or chronic (Narita et al ., 2006).”
BackgroundKarimi‐Haghighi, S., & Shaygan, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04814-8 · Cited by 6
“Furthermore, chronic pain has been found to impair opioidergic function in the cortex and amygdala of mice, which coincided with behavioral abnormalities [71, 72].”
Li, X., Xiong, M., Gao, Y., Xu, X., & Ke, C. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110808 · Cited by 5
Chu, R., Lu, Y., Fan, X., Lai, C., Li, J., Yang, R., Xiang, Z., Han, C., Tian, M., & Yuan, H. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2304082 · Cited by 7
Chronic migraine caused a higher rate of tendency to cannabinoid agonist compared to morphine.
Mansoori, M., Zarei, M. R., Chamani, G., Nazeri, M., Mohammadi, F., Alavi, S. S., & Shabani, M. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i4.8799 · Cited by 5
Tavares, L. R. R., Petrilli, L. A., Baptista‐de‐Souza, D., Canto‐de‐Souza, L., Planeta, C. S., Guimarães, F. S., Nunes‐de‐Souza, R. L., & Canto‐de‐Souza, A. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0300 · Cited by 6
Is finding the common biological link(s) between pain and affect an infinity quest?
Bourbia, N., & Pertovaara, A. (2011) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2011.05.001 · Cited by 5
Effects of acute pain medications on posttraumatic stress symptoms in early aftermath of trauma
Grau, A. S., Xie, H., Redfern, R. E., Moussa, M., Wang, X., & Shih, C.-H. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000413 · Cited by 4
“Both animal and human studies demonstrated that MORs and delta opioid receptors mediate the effects of opioids on anxiety (Filliol et al., 2000; Liberzon et al., 2002; Narita et al., 2006; Wilson and Junor, 2008; Wittmann et al., 2009).”
BackgroundBlack, J. W., & Meyer, L. H. (1992) · PubMed · Cited by 11
Abelson, K., & Grøndahl, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822215-7.00015-9 · Cited by 4
Legg, E. D., Novejarque, A., & Rice, A. S. C. (2009) · Pain · doi:10.1016/j.pain.2009.04.023 · Cited by 5
“Techniques previously employed to reveal the impact of peripheral nerve injury on the morphology and the function of relevant brain areas such as the prefrontal cortex and the amygdala [4,9,11,12] should be applied to animals of various ages.”
BackgroundNisbett, K. E., & Koob, G. F. (2025) · eNeuro · doi:10.1523/eneuro.0059-25.2025 · Cited by 3
“For example, the intracerebroventricular and intra-amygdalar administration of the selective μ -opioid receptor antagonist, CTOP, and selective κ -opioid receptor agonist, dynorphin A, similarly increased anxiety-like behavior of mice in the light/dark box (Narita et al., 2006).”
Top 60 Medications Used for Orofacial Pain Treatment
Clark, G. T. (2008) · Journal of the California Dental Association · doi:10.1080/19424396.2008.12224234 · Cited by 5
Kappa Opioids: Problems and Opportunities in Analgesia
Butelman, E. R., & Kreek, M. J. (2013) · ACS symposium series · doi:10.1021/bk-2013-1131.ch013 · Cited by 4
Neuropeptidases, Stress, and Memory—A Promising Perspective
Prieto, I., Segarra, A. B., de Gasparo, M., & Ramírez‐Sánchez, M. (2016) · AIMS neuroscience · doi:10.3934/neuroscience.2016.4.487 · Cited by 4
Zarrindast, M., Hajikarimloo, B., Raissi-Dehkordi, N., Raissi-Dehkordi, N., & Khakpai, F. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.10.007 · Cited by 3
Chronic inflammatory pain suppresses alcohol intake and accumbal dopamine response
Cuitavi, J., Riera-Calabuig, A., Campos‐Jurado, Y., Lorente, J. D., de Jorge, M., Polache, A., & Hipólito, L. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.105974 · Cited by 3
“…novel evidence that the inflammatory pain model based on a single CFA injection, concomitant with alcohol exposure, lasts for longer periods than previously reported in rats without alcohol exposure (Narita et al., 2006; Parent et al., 2012; Coderre and Laferri ` ere, 2020; Kremer et al., 2021).”
Burning Mouth Syndrome: Is it a neuropathic disease and does having this disease change your brain?
Clark, G. T. (2010) · doi:10.11264/jjop.3.7 · Cited by 4
Wu, Y., Chen, Y., Xu, Y., Ni, W., Lin, C., Shao, X., Shen, Z., He, X., Wang, C., & Fang, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03415-7 · Cited by 3
“Also, a pain state may produce physiological alterations in opioid transmission in the amygdala [18].”
BackgroundClark, G. T., Gutierrez, M. A., Venturin, J. S., & Richeimer, S. H. (2012) · Wiley eBooks · doi:10.1002/9781118704851.ch8 · Cited by 2
Top 60 Most Important Medications Used in an Orofacial Pain Treatment Center
Clark, G. T. (2012) · Wiley eBooks · doi:10.1002/9781118704851.ch2 · Cited by 2
Wing, J. (2013) · e-space (Manchester Metropolitan University) · Cited by 4
A model for irritable bowel syndrome and anxiety comorbidities in relation to alcohol use disorders
Vashkevich, K., Janiuk, K., & Maleki, N. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1161130 · Cited by 1
“Both studies suggest that the comorbidity of anxiety and chronic pain is due to changes in the brain, whether involving connectivity patterns or receptor function (38, 39).”
BackgroundCole, J., & Logan, T. (2024) · Journal of Drug Issues · doi:10.1177/00220426241252336 · Cited by 1
“…that the interplay between increased sensitivity to pain and negative affect found among individuals who misuse opioids (Carcoba et al., 2011; Narita et al., 2006) may cause increasingly intense negative states that exceed the individual ’ s tolerance, prompting further opioid use (Tull et…”
Fear-learning is altered in a mouse neuropathic pain model
Assareh, N., Sokolaj, E. E., Sadia, S., Anderson, K. E., Frith, C., Walls, O. B., Mitchell, V. A., Vaughan, C. W., & Winters, B. L. (2025) · Frontiers in Pain Research · doi:10.3389/fpain.2025.1648374 · Cited by 1
“More recent studies have shown that animal neuropathic pain models also induce anxiety and depression-like behaviours, becoming apparent at approximately 4-weeks following nerve injury (10 – 14).”
InfluentialBodnár, É., Ibos, K. E., Filkor, K., & Csabafi, K. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174098 · Cited by 1
Khalaveh, M., Azizbeigi, R., Taslimi, Z., & Haghparast, A. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115428 · Cited by 1
Evaluation method for a pain-like action
Narita, M., & Suzuki, T. (2007) · Folia Pharmacologica Japonica · doi:10.1254/fpj.130.124 · Cited by 1
Self-citationSaruta, K., Fukutoku, T., Kumagai, G., Nagaoki, T., Tsukuda, M., Nitobe, Y., Wada, K., Asari, T., Fujita, T., Sasaki, I., et al. (2023) · Neurotrauma Reports · doi:10.1089/neur.2022.0071 · Cited by 1
“acute administration of ETZ to the sciatic nerve ligation model mouse improved anxiety behavior.(28) However, this study assessed anxiety behavior after the drug”
BackgroundMethodStructures et mécanismes cérébraux impliqués dans les aspects émotionnels et cognitifs de la douleur
Grégoire, S., Muller, É., & Marchand, F. (2010) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/j.douler.2010.07.001 · Cited by 4
Nakae, A., & Mashimo, T. (2010) · PAIN RESEARCH · doi:10.11154/pain.25.199 · Cited by 2
[A psychosomatic theory of allergic sensitization; allergy as a quasi conditioned reaction].
Hansen, O. (1981) · PubMed · Cited by 3
Wells, L. T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_57 · Cited by 1
Relationship between pain and anxiety in rats
Roeska, K. (2010) · Gutenberg Open Science · doi:10.25358/openscience-1591 · Cited by 1
Kappa Opioid System Involvement in Mood and Anxiety Disorders
Taylor, G. T., & Huffman, J. N. (2017) · International Journal of Neurology Research · doi:10.17554/j.issn.2313-5611.2017.03.70 · Cited by 1
DeMarco, G. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012373898-1.50030-9
The Interaction of Pain and Morphine on Analgesia, Locomotion, and Cognitive Functioning
Baiamonte, B. A. (2010) · ScholarWorks @ The University of New Orleans (The University of New Orleans)
Radke, A. K. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
Gomes, J. M. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2010.tde-09042010-003847
Le récepteur opioïde delta: une nouvelle cible thérapeutique pour la douleur mais plus encore...
Gavériaux‐Ruff, C. (2009) · Douleur et Analgésie · doi:10.1007/s11724-009-0146-3
Complexe amygdalien, douleurs et analgésie
Veinante, P. (2009) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/j.douler.2009.09.013 · Cited by 1
O02 Récepteurs opioïdes mu/delta et analgésie
Gavériaux‐Ruff, C. (2007) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/s1624-5687(07)73099-8
Social modulation and communication of pain in the laboratory mouse
Langford, D. J. (2010) · doi:10.82308/12349 · Cited by 1
A Pain in the Brain: How PACAP CeA Infusion Alters Mechanical and Thermal Sensitivity
Huessy, J. G. (2015) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
The Stress Reducing Effects of Acupuncture in a Rat Model of Chronic Stress
Eshkevari, L. (2010) · DigitalGeorgetown (Georgetown University Library)
Leite‐Almeida, H. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Nakae, A. (2016) · Springer eBooks · doi:10.1007/978-4-431-54598-9_6 · Cited by 1
Distinguishing and connecting self and others
Cui, F. (2013)
Behavioural Co-morbidities in Rat Models of Neuropathic Pain
Legg, E. D. (2011) · Spiral (Imperial College London) · doi:10.25560/9070
Targeting Opioid Receptors for Innovative Antidepressant Therapies: Rediscovering the Opioid Cure
Darcq, E., Chung, P. C. S., Kieffer, B. L., & Lutz, P.-É. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_38
Ko, M. J., Chiang, T., Mukadam, A. A., Mulia, G. E., Gutridge, A. M., Lin, A., Chester, J. A., & van Rijn, R. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/790568
“59), which is in line with reports that the δOR antagonist, naltrindole, is anxiogenic (60).”
BackgroundGross, J. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.4060
Effects of antidepressants on the ventral dentate gyrus
Arias, E. C. (2021) · Columbia Academic Commons (Columbia University) · doi:10.7916/d8-4gaa-1e71
Carmona, I. M., de Oliveira, P. E. C., Baptista‐de‐Souza, D., & Canto‐de‐Souza, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.472930
Cuitavi, J., Riera-Calabuig, A., Campos‐Jurado, Y., Lorente, J. D., Polache, A., & Hipólito, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4547464/v1
Liu, A.-R., Lin, Z., Wei, M., Tang, Y., Zhang, H., 彭向阁, Li, Y., Zheng, Y.-F., Tan, Z., Zhou, L.-J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26628997
Conditional gene knockout approach to investigate Delta opioid receptor functions in the forebrain
Chung, P. C. S. (2013) · theses.fr (ABES) · doi:10.70675/a9fa1695z619dz4e30zb138zea0ead936150
“(2013), http:// Approach Model/compound Test Delta compou (route/dose) Genetic DOR KO mice Elevated plus maze Light-dark box Open field Enk KO mice Open field Elevated O-maze Resident-intruder test Light-dark box Fear conditioning DOR antagonist Rats/NTI Elevated plus maze s.c. (1, 3 or 5 m Elevated plus maze Local in…”
InfluentialThe ACC is a critical hub for neuropathic pain-induced depression
Sellmeijer, J. (2016) · theses.fr (ABES) · doi:10.70675/a4602e02z1c7az4a9dzb530z78a0ad19a0b8
Mécanismes de chronicisation de la douleur post-opératoire
Tassou, A. (2020) · theses.fr (ABES) · doi:10.70675/ca784204zd9abz41a2zbb2ezf5abac616807 · Cited by 3
Neuropathic pain and depression : molecular alterations in the anterior cingulate cortex
Humo, M. (2019) · theses.fr (ABES) · doi:10.70675/e72f9364z66cbz45c4z8b42zb7f3564cd3d0
Role of relaxin-3/RXFP3 forebrain networks in the descending control of pain in the mouse.
Covita, J. (2019) · theses.fr (ABES) · doi:10.70675/41ac8038ze557z4d9ez8dbdz73f9521d05c6
“Despite using mice of the same strain, age, and sex, and similar doses of saline and CFA, the current studies did not replicate the results of the earlier study (Narita et al., 2006).”
BackgroundResultLe récepteur 5-HT6, une nouvelle cible pour le traitement des douleurs neuropathiques
Martin, P.-Y. (2018) · theses.fr (ABES) · doi:10.70675/07f1c1dcz43f2z4752zbafcz43480dae7825
Contrôle peptidergique de la douleur : modulation des voies descendantes par les systèmes relaxine.
Abboud, C. (2021) · theses.fr (ABES) · doi:10.70675/d4d32122z1374z427ezae6dzda0f030e61ca
Contribution of the amygdalo-cingulate pathway in depression and its comorbidity with chronic pain
Becker, L. J. (2021) · theses.fr (ABES) · doi:10.70675/cdeda10fz3bbdz4a8cza740z361352fc379b
Ulans, A., & Jacobs, L. (2026) · Animals · doi:10.3390/ani16111657
Peripheral and Central Mechanisms of Opioid-induced Constipation
Li, Y., & Wang, Z. (2026) · Neuropharmacology and Therapy · doi:10.15212/npt-2026-0014
Abdallah, K., & Yalçın, İ. (2025) · Dunod eBooks · doi:10.3917/dunod.poisb.2025.01.0841
Enkephalin constrains fear learning via volume transmission to the lateral amygdalaPreprint
Wang, R., Yau, J. O.-Y., Kalra, M., Gilchrist, S., Livermore, A., Gregoriou, G. C., Schennink, M., Moreno, C., Santhakumar, R., Rafiei, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.17.739254
Racing Against Time: Understanding the Temporal Dynamics of Anxiety and Depression in Chronic Pain
Srinivasan, V. S. V., Lima, S., Mathis, V., & Yalçın, İ. (2026) · Neuromethods · doi:10.1007/978-1-0716-5312-8_14
Enkephalin constrains fear learning via volume transmission to the lateral amygdalaPreprint
Bagley, E. E., Wang, R., Yau, J. O.-Y., Kalra, M., Gilchrist, S., Livermore, A., Gregoriou, G. C., Schennink, M., Moreno, C., Santhakumar, R., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10600205/v1
“…tone, such as those produced by opioid withdrawal-driven upregulation of peptidase activity [35] or chronic pain-induced suppression of opioid release [53], would not simply reduce signal magnitude but shift the balance between distinct intracellular signalling cascades across the ASt-LA network.”
The Intraplantar CFA Inflammatory Pain Model Incompletely Captures Pain Comorbidities Across Sexes
Fenech, C. E., Assareh, N., & Aubrey, K. R. (2026) · Journal of Neuroscience Research · doi:10.1002/jnr.70157
“…effect (Burek et al. 2021; Cardenas et al. 2021; Chen et al. 2013; Flores-García et al. 2025; Gaspar et al. 2021; Hofmann et al. 2017; Liu et al. 2015; Narita et al. 2006; Parent et al. 2012; Pitzer et al. 2016, 2019; Refsgaard et al. 2016; Sheahan et al. 2017; Urban et al. 2011; Zhou et al. 2019).”
InfluentialBehavioral and immunolgical effects of repeated social defeat
Kinsey, S. G. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Metadata
- Authors
- Narita, M., Kaneko, C., Miyoshi, K., Nagumo, Y., Kuzumaki, N., Nakajima, M., Nanjo, K., Matsuzawa, K., Yamazaki, M., & Suzuki, T.
- Affiliations
- Hoshi University (JP)
- University of Toyama (JP)
- Corresponding author
- Narita, Minoru
- Suzuki, Tsutomu
- Venue
- Neuropsychopharmacology
- Published
- 2005-08-10
- Volume
- 31
- Issue
- 4
- Pages
- 739-750
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2019397294
- Cited by
- 289
- References
- 42
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 11 · 2021: 19 · 2020: 25 · 2019: 17 · 2018: 16 · 2017: 10 · 2016: 11 · 2015: 19 · 2014: 19 · 2013: 12 · 2012: 10
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- chronic pain, anxiety, amygdala, opioid system, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, dynorphin A, neuropathic pain, sciatic nerve ligation, complete Freund's adjuvant, thermal hyperalgesia, GTPgammaS binding, anxiogenic effects
- MeSH terms
- Amygdala, Analgesics, Opioid, Analysis of Variance, Animals, Anxiety, Behavior, Animal, Benzamides, Chronic Disease, Diazepam, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Interactions, Dynorphins, Freund's Adjuvant, Injections, Intraventricular, Male, Mice, Inbred C57BL, Naltrexone, Narcotic Antagonists, Narcotics, Pain, Pain Measurement, Piperazines, Protein Binding, Pyrrolidines, Reaction Time, Sciatica, Somatostatin, Sulfur Isotopes, Time Factors, Tranquilizing Agents, Guanosine 5'-O-(3-Thiotriphosphate), Rats, Sprague-Dawley, Maze Learning, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.